CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
TETUS aims to accelerate the commercial launch of MukoCell®, a cell product addressing an unmet medical need. The project focuses on obtaining market authorization across Europe to facilitate reimbursement strategies and increase sales significantly in the coming years.
TETUS will address commercialisation complexities related to cell products and prepares MukoCell® for accelerated commercialisation by facilitating an EU-wide Market Authorisation.
As MukoCell® addresses an unmet medical need, it is eligible to use an EU-accelerated market access pathway.
Once Marketing Authorisation is in place, country-specific reimbursement strategies and market access (financial) plans can be developed that are requirments of for MukoCell® ready to go to market.Therefore, a…
MUKOCELL GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
